The 50th edition of the Arab Health Exhibition & Congress opened today at the Dubai World Trade Centre, featuring a substantial Indian presence of 361 companies showcasing the nation’s pharmaceutical and healthcare capabilities. The event, running from January 27-30, 2025, arrives as industry projections indicate the global healthcare market could reach US$780 billion by 2030.
The Indian contingent, backed by the Ministry of Commerce and Industry and coordinated by the Pharmaceuticals Export Promotion Council of India (Pharmexcil), comprises 65 companies in the Pharmexcil Pavilion and 22 medical device manufacturers in the EEPC Pavilion. Leading organizations including HLL Lifecare Ltd., Bharat Parenterals Ltd., and Zuvius Lifesciences Pvt. Ltd. are demonstrating their innovations in pharmaceutical formulations, nutraceuticals, oncology products, and active pharmaceutical ingredients.
This milestone edition of Arab Health has drawn unprecedented international participation, with over 40 country pavilions including first-time exhibitors Morocco and Latvia. The consumer healthcare market, valued at US$360 billion in 2023, is projected to grow at a compound annual growth rate of 8.8% through 2030.
The event serves as a strategic platform for India’s healthcare sector to strengthen its presence in the Middle East market and showcase its capabilities in providing affordable, high-quality healthcare solutions.
